PENTASA (mesalamine controlled-release capsules) Patient Assistance Program
Important 2026 update: Takeda’s Help at Hand program has stopped accepting new Pentasa patients and ends Pentasa coverage entirely on December 31, 2026 — because generic mesalamine ER has arrived. If you rely on the program, you need a transition plan now. We build it and manage it for a flat $69.95 per month.
- Honest, Current Guidance — The Assistance Landscape For Pentasa Changed In July 2026
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Pentasa (Mesalamine Controlled-Release) Treats Mild-To-Moderate Ulcerative Colitis Throughout The Entire GI Tract — Its Ethylcellulose-Coated Granules Release Mesalamine From The Stomach Onward, Unlike Colon-Targeted Mesalamines.
- Brand Cash Prices Run Roughly $1,440+ Per Month At The Standard 4 g/Day Dose. Generic Mesalamine ER Capsules Are Now Real: Sun Pharma Has Marketed Since 2022, And Sandoz And DifGen Launched In 2026, With Prices Already ~20% Below Brand And Falling.
- The Big 2026 Change: Takeda’s Help At Hand Stopped Accepting New Pentasa Applications On July 1, 2026, And Ends Pentasa Coverage Entirely On December 31, 2026. Existing Enrollees Keep Free Medication Only Through Year-End — Then Need A New Plan.
- The Transition Options: Switch To Generic Mesalamine ER (Pharmacist-Substitutable), Use The $2,100 Medicare Part D Cap, Or — For Complex Cases — Have Your GI Document Why A Specific Formulation Matters. We Map The Right One Before The Deadline.
What Is Pentasa Prescription Assistance Program?
For years, the Pentasa Patient Assistance Program meant Takeda Help at Hand — free medication at household incomes up to 500% of the Federal Poverty Level. That era is ending on a schedule: as of July 1, 2026, Help at Hand no longer accepts new Pentasa applications, and after December 31, 2026, Pentasa leaves the program entirely. This follows a standard industry pattern — manufacturers retire assistance for drugs once generics arrive, and generic mesalamine ER capsules are now marketed by Sun Pharma, Sandoz, and DifGen. What replaces the program is a decision, not a form: for most patients, pharmacist-substitutable generic mesalamine ER at a growing discount; for Medicare patients, the $2,100 Part D cap; for the minority whose disease control is sensitive to formulation, a GI-documented case for a specific product. Existing Help at Hand enrollees (1-800-830-9159) keep coverage through year-end — which makes the next months the planning window, not the panic window. For a flat $69.95 per month, our Patient Advocates price every route for your exact situation and manage the switch before the deadline does it for you.
Pharmacy Price Comparison
- Without assistance, brand Pentasa costs roughly $700–$1,000/month. Generic mesalamine controlled-release is dramatically cheaper. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$950 | Save ~$880/mo |
| CVS Pharmacy (brand) | ~$1,000 | Save ~$930/mo |
| Walmart (brand) | ~$750 | Save ~$680/mo |
| Costco (brand) | ~$730 | Save ~$660/mo |
Generic mesalamine CR | ~$200 | Generic — lower |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Pentasa Prescription Program?
The programs themselves are free — what patients need in 2026 is the transition managed correctly. Our $69.95/month service covers full advocacy: pricing the generic against your plan, coordinating substitution with your GI, and making sure December 31 arrives with your January fill already solved.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Pentasa:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $700–$1,000 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
The question for Pentasa in 2026 is which route you qualify for. Contact AffordMyPrescriptions so we can review your case — and if you’re an existing Help at Hand enrollee, do it before the December 31 cutoff:
- You Are An Existing Help At Hand Pentasa Enrollee — Coverage Continues Only Through December 31, 2026; Transition Planning Should Start Now
- You Are A New Patient — The PAP Is Closed; The Generic Route Is Almost Certainly Your Answer
- You Are On Medicare — The $2,100 Part D Cap Plus Generic Pricing Sets Your Worst Case
- Your Disease Control Is Formulation-Sensitive — A GI-Documented Product Case Is Worth Building
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Pentasa:
Pentasa (mesalamine controlled-release) is a 5-aminosalicylate (5-ASA) — the foundational anti-inflammatory for mild-to-moderate ulcerative colitis — in a formulation designed to treat the whole length of the GI tract.
How Pentasa Works:
Mesalamine acts directly on the intestinal lining, damping the local inflammatory cascade that drives UC’s ulceration and bleeding — a topical effect from the inside, with minimal systemic absorption. Formulation is the entire product story in the 5-ASA class: Pentasa’s ethylcellulose-coated microgranules release drug continuously from the stomach through the colon, while competitors like Asacol/Delzicol (pH-triggered) and Lialda (colon-targeted) release further downstream. That’s why formulation-switching in 5-ASAs is a clinical conversation — and why the new AB-rated generics of Pentasa’s own formulation matter so much: they’re the same release profile, substitutable at the counter.
Form and Use:
Controlled-release capsules (250 mg and 500 mg), typically 1 g four times daily for active UC — a high pill burden that makes per-capsule pricing decisive. Maintenance continues long-term; 5-ASA adherence is one of the strongest predictors of staying in remission, which makes an uncovered January exactly the relapse risk the transition plan exists to prevent.
Generic Availability:
Real and growing: Sun Pharma has marketed generic mesalamine ER 500 mg since 2022, DifGen received approval for both strengths in March 2026, and Sandoz began marketing in July 2026. Prices currently run about 20% below brand and should fall further as competition deepens — the same dynamic that led Takeda to retire Pentasa from Help at Hand. Ask your pharmacist for the generic by default.
Warnings:
Mesalamine can rarely cause an acute intolerance syndrome mimicking a UC flare (cramping, bloody diarrhea) — report worsening symptoms rather than assuming treatment failure. Kidney function should be checked periodically (rare interstitial nephritis), and patients allergic to salicylates or sulfasalazine should discuss risks. Stay hydrated, and tell your prescriber about NSAID use.
FAQ (Frequently Asked Questions)
How Much Does Pentasa Cost Without Insurance?
Yes. Takeda’s Help at Hand stopped accepting new Pentasa applications on July 1, 2026, and Pentasa leaves the program entirely after December 31, 2026. Existing enrollees keep free medication through year-end. This follows the standard pattern when generics launch — the same thing happened to other brands across the industry this year.
What Should Existing Enrollees Do Before December 31
Three things, in order: have your GI confirm whether generic mesalamine ER is appropriate (for most patients, yes); get the generic priced against your insurance now, not in January; and if you’re formulation-sensitive, start the documented-necessity conversation early. We run all three as one managed transition.
How Much Does Pentasa Cost Without The Program?
Brand runs roughly $1,440+ per month at the standard 4 g/day dose. Generic mesalamine ER currently prices about 20% below brand and is falling as Sandoz and DifGen ramp up — check current pricing at fill time, because this market is moving quarter by quarter.
Is Generic Mesalamine ER Really Equivalent To Pentasa?
The marketed generics are AB-rated to Pentasa — same formulation approach, same release profile, pharmacist-substitutable. That’s different from switching between 5-ASA brands (Lialda, Asacol), which release differently and require a clinical decision. Generic Pentasa is the low-risk switch.
Does Medicare Cover Pentasa?
Yes — under Part D, with the $2,100 annual out-of-pocket cap (2026) as your worst case, and generic pricing improving the picture underneath it. Extra Help applies if income-qualified
Is There A Copay Card?
Yes — under Part D, with the $2,100 annual out-of-pocket cap (2026) as your worst case, and generic pricing improving the picture underneath it. Extra Help applies if income-qualified.
No active manufacturer card exists for Pentasa. With generics on the market, none is likely to return — the generic is the discount now.
What If I Flare During The Transition
That’s why the plan happens before the deadline: an uncovered gap in 5-ASA maintenance is a known relapse risk. We sequence the switch so there is no uncovered month — and if a flare needs escalation beyond 5-ASAs, that’s a GI conversation where cost planning starts over with new drugs, which we also handle.
Take Control of Your Medication Costs
Pentasa’s assistance program is ending on a known date — which means nobody has to be surprised by it. Generic pricing, Medicare caps, and a managed December transition cover every situation we’ve seen. Check your eligibility today; the pre-qualification review is free, and if we can’t help you, you pay nothing.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.